Stock Taper
SCREENER COMPARE ANY 2 STOCKS
NRSN
NEUROSENSE THERAPEUTICS LTD.
NASDAQ
$0.42
▼ DOWN 18.15% (-0.09)

KEY STATISTICS

Market Cap$15.54 M
52w High$1.98
52w Low$0.25
Dividend Yield—
Frequency—
P/E-0.81
Volume1.02M
Shares Out.35.35M

COMPANY

LEADERSHIP

Alon Ben-Noon
CHIEF EXECUTIVE
Alon Ben-Noon

ABOUT

SECTOR
Healthcare
WENT PUBLIC
December 9, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
17

UPCOMING EARNINGS

DateDec 2, 2026
DayWednesday
Rev. Est.$535.60K
DEC
2
WED

PRICE

$0.42 ▼ DOWN 18.15% (−$0.09)
$0.40$0.45$0.509:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM0.42

About NeuroSense Therapeutics Ltd.

https://www.neurosense-tx.com ↗

NeuroSense Therapeutics Ltd., a clinical-stage biotech in Herzliya, Israel, develops treatments for neurodegenerative diseases, with lead product PrimeC in Phase IIa for ALS and pipeline candidates for Parkinson’s and Alzheimer’s.

INDUSTRY

Biotechnology

A PRODUCT NEUROSENSE THERAPEUTICS LTD. IS KNOWN FOR

PrimeC
PrimeC

PrimeC is a clinical-stage, oral combination of FDA-approved ciprofloxacin and celecoxib, targeting ALS mechanisms, completed Phase 2b trials, and is NeuroSense's leading candidate for neurodegenerative disease treatment.

COMPETITORS

COMPETITOR
AMLX COMPARE
BIIB COMPARE
CYTK COMPARE
DNLI COMPARE
IONS COMPARE

INSTITUTIONAL OWNERSHIP

SHARES OWNED
1.63%
HOLDERS
19
TOP 12 OF 19 · RANKED BY POSITION SIZE
Yorkville Advisors Global, LP
100.0K sh · $76.9K
Squarepoint Ops LLC
95.4K sh · $119.22K
Morgan Stanley
66.4K sh · $83K
Two Sigma Investments, LP
51.5K sh · $39.64K
Independent Advisor Alliance
50.0K sh · $37.75K
Ubs Group AG
49.1K sh · $37.07K
Meitav Investment House Ltd
40.0K sh · $30.2K
Gts Securities LLC
35.8K sh · $27.49K
Jane Street Group, LLC
28.7K sh · $21.65K
Commonwealth Equity Services, LLC
22.8K sh · $17.52K
Pnc Financial Services Group, Inc.
21.1K sh · $15.97K
Pathstone Holdings, LLC
16.5K sh · $12.48K

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
OFFICER: CHIEF EXECUTIVE OFFICER
Ben-Noon Alon
Purchase · 250.0K shares
2026-06-16
★
OFFICER: CHIEF FINANCIAL OFFICER
Eisenberg Or
Purchase · 250.0K shares
2026-06-16
★
OFFICER: CHIEF FINANCIAL OFFICER
Eisenberg Or
Purchase · 200.0K shares
2026-03-26
★
OFFICER: CHIEF FINANCIAL OFFICER
Eisenberg Or
— · —
2026-03-18

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
D. Boral Capital BUY

SECTORS PEERS

PEERPRICE
NERV$4.35COMPARE
RLYB$16.52COMPARE
NRXS$5.88COMPARE
TAOX$4.06COMPARE
ENLV$1.10COMPARE
XCUR$1.45COMPARE
CLGN$3.41COMPARE
CVKD$1.23COMPARE